Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Genetic Basis of Hypertrophic Cardiomyopathy
Ali J. Marian
Circulation Research (2021) Vol. 128, Iss. 10, pp. 1533-1553
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Transforming growth factor-β in myocardial disease
Nikolaos G. Frangogiannis
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 435-455
Closed Access | Times Cited: 195
Hearts apart: sex differences in cardiac remodeling in health and disease
Thomas G. Martin, Leslie A. Leinwand
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 18
Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
Sofija Vučković, Rafeeh Dinani, Edgar E. Nollet, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
Bogdan-Sorin Tudurachi, Alexandra Zăvoi, Andreea Leonte, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10510-10510
Open Access | Times Cited: 37
Endothelial cell dysfunction in cardiac disease: driver or consequence?
Jules D. Allbritton‐King, Guillermo Garcı́a-Cardeña
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
MYH7 in cardiomyopathy and skeletal muscle myopathy
Gao Yuan, Lu Peng, Cuifen Zhao
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 2, pp. 393-417
Closed Access | Times Cited: 23
Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future
Mohammed Tiseer Abbas, Nima Baba Ali, Juan Farina, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 682-682
Open Access | Times Cited: 13
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Patryk Skórka, Jakub Piotrowski, Estera Bakinowska, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access | Times Cited: 1
Recent Findings Related to Cardiomyopathy and Genetics
Takanobu Yamada, Seitaro Nomura
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12522-12522
Open Access | Times Cited: 43
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
Maja Schlittler, Peter P. Pramstaller, Alessandra Rossini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14845-14845
Open Access | Times Cited: 22
Hypertrophic cardiomyopathy in MYBPC3 carriers in aging
Kalyani Ananthamohan, Julian E. Stelzer, Sakthivel Sadayappan
The Journal of Cardiovascular Aging (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 6
The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction
Jérôme Lugrin, Roumen Parapanov, Giuseppina Milano, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure
Kyung‐Hee Kim, Naveen L. Pereira
Korean Circulation Journal (2021) Vol. 51, Iss. 10, pp. 797-797
Open Access | Times Cited: 30
circRNA-miRNA-mRNA Deregulated Network in Ischemic Heart Failure Patients
Alisia Madè, Alessia Bibi, José Manuel García-Manteiga, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2578-2578
Open Access | Times Cited: 13
Cardiac myosin binding protein-C phosphorylation as a function of multiple protein kinase and phosphatase activities
Thomas Kampourakis, Saraswathi Ponnam, Kenneth S. Campbell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Single-Cell Analysis Revealed the Role of CD8+ Effector T Cells in Preventing Cardioprotective Macrophage Differentiation in the Early Phase of Heart Failure
Kyoko Komai, Minako Ito, Seitaro Nomura, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Calcium Handling in Inherited Cardiac Diseases: A Focus on Catecholaminergic Polymorphic Ventricular Tachycardia and Hypertrophic Cardiomyopathy
Stéphane Zaffran, Lilia Kraoua, Hager Jaouadi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3365-3365
Open Access | Times Cited: 10
Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population
Ruilin Liu, Yifeng Yang, Ke Wei Gong, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Recent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies
Mengya Zhao, Xianzhen He, Xinwen Min, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 2
Open Access
The Potential of RNA Therapeutics in Treating Cardiovascular Disease
Gayatri Mainkar, Matteo Ghiringhelli, Lior Zangi
Drugs (2025)
Closed Access
Investigating the dual role of mitochondrial and nuclear genome variants in pediatric cardiomyopathies
Mehmet Arda Temena, Ebru Erzurumluoğlu Gökalp, Ezgi Susam, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
Hua Shen, Shi‐Yong Dong, Ming-Shi Ren, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 15
Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy
Natalia Baulina, Maria Pisklova, Ivan Kiselev, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3791-3791
Open Access | Times Cited: 14
Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
María Valero‐Muñoz, Eng Leng Saw, Ryan Hekman, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Discovery of a novel cardiac-specific myosin modulator using artificial intelligence-based virtual screening
Priyanka Parijat, Seetharamaiah Attili, Zoe Hoare, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top